Moroson H, Ioachim H L
Department of Pathology, Lenox Hill Hospital, New York, New York 10021, USA.
Cancer Res. 1995 Aug 15;55(16):3664-8.
Clinical observations and experimental studies have shown that pregnancy may have inhibitory effects on tumor growth rather than invariably aggravate neoplastic disease as believed previously. It has been suggested that circulating factors of maternal or fetal origin may protect against tumor growth during pregnancy. The previously created experimental model of teratomas provides the means of having an adult animal bearing a permanent graft of embryonal tissues. To investigate the potential effects of embryonal factors on the growth of malignant neoplasms, rats carrying grafts of embryonal tissues were subjected to the induction or transplantation of carcinomas and lymphomas. Finely minced embryo tissues or cell suspensions injected in homologous rat recipients formed permanent benign teratomas composed of a variety of well differentiated tissues. One injection of N-methyl-N-nitrosourea, a potent carcinogen administered to all rats, induced fatal mammary adenocarcinoma in 50-60% of control rats but in none of the rats bearing a grafted teratoma. Transplantation of N-methyl-N-nitrosourea-induced mammary adenocarcinoma or Gross virus-induced lymphoma killed 100% of control rats but resulted in smaller, later appearing tumors in only 25-61% of teratoma-bearing rats. The present experiments showed that rats bearing grafts of embryonal tissues in the form of teratomas were partially or totally protected against the induction and transplantation of malignant tumors that killed 100% of controls. These results suggest that the embryonal tissues are a source of tumor-inhibitory factors, which may be a part of mechanisms controlling the growth and detecting the aberrations of embryonal tissues. Their identification and analysis may provide knowledge about embryonal growth and possibly about new substances with antineoplastic activity.
临床观察和实验研究表明,妊娠对肿瘤生长可能具有抑制作用,而并非如之前所认为的那样必然会加重肿瘤疾病。有人提出,母体或胎儿来源的循环因子可能在孕期保护机体免受肿瘤生长的影响。先前建立的畸胎瘤实验模型提供了一种让成年动物携带胚胎组织永久移植物的方法。为了研究胚胎因子对恶性肿瘤生长的潜在影响,将携带胚胎组织移植物的大鼠用于诱导或移植癌和淋巴瘤。将精细切碎的胚胎组织或细胞悬液注射到同源大鼠受体中,形成了由多种高度分化组织组成的永久性良性畸胎瘤。给所有大鼠注射一种强效致癌物N-甲基-N-亚硝基脲,在50-60%的对照大鼠中诱发了致命的乳腺腺癌,但在所有携带移植畸胎瘤的大鼠中均未诱发。移植N-甲基-N-亚硝基脲诱导的乳腺腺癌或格罗斯病毒诱导的淋巴瘤导致100%的对照大鼠死亡,但在仅25-61%的携带畸胎瘤的大鼠中导致肿瘤出现较晚且体积较小。目前的实验表明,以畸胎瘤形式携带胚胎组织移植物的大鼠对导致100%对照大鼠死亡的恶性肿瘤的诱导和移植具有部分或完全的抵抗力。这些结果表明,胚胎组织是肿瘤抑制因子的一个来源,这可能是控制胚胎组织生长和检测其异常的机制的一部分。对它们的鉴定和分析可能会提供有关胚胎生长的知识,并可能提供有关具有抗肿瘤活性的新物质的知识。